Coordinated translational control of multiple immune checkpoints by the integrated stress response pathway in lung
Shayna Thomas-Jardin1, Shruthy Suresh1,2,3, Ariana Arce1
1Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Abstract:
The integrated stress response (ISR) is an adaptive pathway hijacked by cancer cells to survive cellular stresses in the tumor microenvironment. ISR activation potently induces Programmed Death Ligand 1 (PD-L1), leading to suppression of anti-tumor immunity. Here we sought to uncover additional immune checkpoint proteins regulated by the ISR to elucidate mechanisms of tumor immune escape. We show that CD155 and PD-L1 are coordinately induced by the ISR, enhancing translation of both immune checkpoint proteins through bypass of inhibitory upstream open reading frames (uORFs) in their 5' UTRs. Analysis of primary human lung tumors identifies a significant correlation between PD-L1 and CD155 expression. ISR activation accelerates tumorigenesis and inhibits T cell function, effects that can be overcome by combining PD-1 blockade with the ISR inhibitor ISRIB. These studies uncover a novel mechanism by which two immune checkpoint proteins are coordinately regulated and suggest a new therapeutic strategy for lung cancer patients.
Statement Of Significance:
This study uncovers a novel mechanism for the coordinated translational regulation of the PD-L1/PD1 and CD155/TIGIT immune checkpoint pathways and highlights the ISR as a therapeutic vulnerability for lung cancer. Inhibition of the ISR pathway bolsters PD-1 blockade, potentially unveiling a new therapeutic strategy for lung cancer patients.
Insights
The integrated stress response (ISR) pathway promotes cancer immune evasion by upregulating PD-L1 and CD155. Inhibiting the ISR enhances anti-cancer immunity, offering a new therapeutic strategy for lung cancer.
Area of Science:
- Cancer immunology
- Molecular biology
- Tumor microenvironment
Background:
- The integrated stress response (ISR) is crucial for cancer cell survival under stress.
- ISR activation leads to Programmed Death Ligand 1 (PD-L1) induction, suppressing anti-tumor immunity.
- Tumor immune escape mechanisms involve multiple immune checkpoint proteins.
Purpose of the Study:
- To identify additional immune checkpoint proteins regulated by the ISR.
- To elucidate the mechanisms of ISR-mediated tumor immune escape.
- To explore novel therapeutic strategies for lung cancer.
Main Methods:
- Analysis of ISR-regulated gene expression and protein translation.
- Investigating the role of upstream open reading frames (uORFs) in 5' UTRs.
- Correlative analysis of PD-L1 and CD155 expression in primary human lung tumors.
- Evaluating the efficacy of combined PD-1 blockade and ISR inhibition (ISRIB) in preclinical models.
Main Results:
- The ISR coordinately induces both PD-L1 and CD155 expression.
- ISR activation enhances the translation of PD-L1 and CD155 by bypassing inhibitory uORFs.
- A significant correlation between PD-L1 and CD155 expression was observed in human lung tumors.
- ISR activation accelerates tumorigenesis and impairs T cell function.
- Combined PD-1 blockade and ISR inhibition overcome these effects.
Conclusions:
- The ISR represents a novel regulatory mechanism for coordinated immune checkpoint protein expression.
- The ISR pathway is a therapeutic vulnerability in lung cancer.
- Combining PD-1 blockade with ISR inhibition presents a promising new therapeutic strategy for lung cancer patients.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Psychoneuroimmunology: Diabetes and Cancer
Regulation of the Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway


